BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 33736633)

  • 1. Up-regulation of sex-determining region Y-box 9 (SOX9) in growth hormone-secreting pituitary adenomas.
    Shirian FI; Ghorbani M; Khamseh ME; Imani M; Panahi M; Alimohammadi A; Nourbakhsh M; Salimi V; Tavakoli-Yaraki M
    BMC Endocr Disord; 2021 Mar; 21(1):50. PubMed ID: 33736633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of growth hormone secretagogue receptor type 1a mRNA expression in human growth hormone-secreting pituitary adenoma harboring G protein alpha subunit mutation.
    Xu T; Ye F; Wang B; Tian C; Wang S; Shu K; Guo D; Lei T
    Neuro Endocrinol Lett; 2010; 31(1):147-54. PubMed ID: 20150876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas.
    Chang M; Wang Z; Gao J; Yang C; Feng M; Niu Y; Tong WM; Bao X; Wang R
    J Clin Endocrinol Metab; 2022 Jan; 107(1):136-149. PubMed ID: 34491359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of microRNAs in GH-secreting pituitary adenomas.
    Mao ZG; He DS; Zhou J; Yao B; Xiao WW; Chen CH; Zhu YH; Wang HJ
    Diagn Pathol; 2010 Dec; 5():79. PubMed ID: 21138567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor-regulated tyrosine kinase substrate (HGS) and guanylate kinase 1 (GUK1) are differentially expressed in GH-secreting adenomas.
    da Rocha AA; Giorgi RR; de Sa SV; Correa-Giannella ML; Fortes MA; Cavaleiro AM; Machado MC; Cescato VA; Bronstein MD; Giannella-Neto D
    Pituitary; 2006; 9(2):83-92. PubMed ID: 16832584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glucose-dependent insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cells.
    Occhi G; Losa M; Albiger N; Trivellin G; Regazzo D; Scanarini M; Monteserin-Garcia JL; Fröhlich B; Ferasin S; Terreni MR; Fassina A; Vitiello L; Stalla G; Mantero F; Scaroni C
    J Neuroendocrinol; 2011 Jul; 23(7):641-9. PubMed ID: 21554434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locally produced estrogen through aromatization might enhance tissue expression of pituitary tumor transforming gene and fibroblast growth factor 2 in growth hormone-secreting adenomas.
    Ozkaya HM; Comunoglu N; Keskin FE; Oz B; Haliloglu OA; Tanriover N; Gazioglu N; Kadioglu P
    Endocrine; 2016 Jun; 52(3):632-40. PubMed ID: 26578364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rab18 is reduced in pituitary tumors causing acromegaly and its overexpression reverts growth hormone hypersecretion.
    Vazquez-Martinez R; Martinez-Fuentes AJ; Pulido MR; Jimenez-Reina L; Quintero A; Leal-Cerro A; Soto A; Webb SM; Sucunza N; Bartumeus F; Benito-Lopez P; Galvez-Moreno MA; Castaño JP; Malagon MM
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2269-76. PubMed ID: 18349058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and functional properties of densely and sparsely granulated GH-producing pituitary adenomas.
    Mayr B; Buslei R; Theodoropoulou M; Stalla GK; Buchfelder M; Schöfl C
    Eur J Endocrinol; 2013 Oct; 169(4):391-400. PubMed ID: 23847328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone-secreting adenomas: pathology and cell biology.
    Lopes MB
    Neurosurg Focus; 2010 Oct; 29(4):E2. PubMed ID: 20887127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
    Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.
    Sakai N; Kim K; Sanno N; Yoshida D; Teramoto A; Shibasaki T
    Neurol Med Chir (Tokyo); 2008; 48(11):481-7; discussion 487-8. PubMed ID: 19029774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion.
    Zhou C; Jiao Y; Wang R; Ren SG; Wawrowsky K; Melmed S
    J Clin Invest; 2015 Apr; 125(4):1692-702. PubMed ID: 25774503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Alterations and Complex Subclonal Architecture in Sporadic GH-Secreting Pituitary Adenomas.
    Hage M; Viengchareun S; Brunet E; Villa C; Pineau D; Bouligand J; Teglas JP; Adam C; Parker F; Lombès M; Tachdjian G; Gaillard S; Chanson P; Tosca L; Kamenický P
    J Clin Endocrinol Metab; 2018 May; 103(5):1929-1939. PubMed ID: 29474559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic glucose status and pituitary pathology portend therapeutic outcomes in acromegaly.
    Cheng S; Al-Agha R; Araujo PB; Serri O; L Asa S; Ezzat S
    PLoS One; 2013; 8(9):e73543. PubMed ID: 24039977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary Adenomas.
    Gatto F; Feelders RA; Franck SE; van Koetsveld PM; Dogan F; Kros JM; Neggers SJCMM; van der Lely AJ; Lamberts SWJ; Ferone D; Hofland LJ
    J Clin Endocrinol Metab; 2017 Jun; 102(6):2009-2018. PubMed ID: 28323931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of sFRP4 as a bio-marker for predicting aggressiveness and recurrence of growth hormone-secreting pituitary adenomas.
    Wu Y; Liu C; Yu S; Gao H; Li Z; Li C; Zhang Y
    Oncol Rep; 2016 May; 35(5):2991-9. PubMed ID: 26935389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of survivin splice variants in pituitary tumors.
    Waligórska-Stachura J; Andrusiewicz M; Sawicka-Gutaj N; Kubiczak M; Jankowska A; Liebert W; Czarnywojtek A; Waśko R; Blanco-Gangoo AR; Ruchała M
    Pituitary; 2015 Jun; 18(3):410-6. PubMed ID: 25107550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel somatic variants involved in biochemical activity of pure growth hormone-secreting pituitary adenoma without GNAS variant.
    Ku CR; Lim H; Lee YJ; Kim SH; Kim D; Kim SH; Lee MK; Bang D; Lee EJ
    Sci Rep; 2021 Aug; 11(1):16530. PubMed ID: 34400688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acromegaly without imaging evidence of pituitary adenoma.
    Lonser RR; Kindzelski BA; Mehta GU; Jane JA; Oldfield EH
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4192-6. PubMed ID: 20610592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.